Dr. George R. Bou Samra, MD

Dr. Bou Samra practices at Somerset Cardiology in Somerset, Pennsylvania.

Dr. Bou Samra's NPI, 1447369020, was assigned on August 29, 2006. Dr. Bou Samra holds Pennsylvania license MD-067949-L.

Dr. Bou Samra's primary practice is Somerset Cardiology, at 329 S Pleasant Ave, Somerset, PA 15501 in Somerset County. The practice phone is (814) 445-7101.

Dr. Bou Samra's primary practice is Somerset Cardiology in Somerset, Pennsylvania. Dr. Bou Samra is also affiliated with UPMC Somerset. The medical group on file is UPMC Primary Care, Somerset Family Practice. Dmand AI also links Dr. Bou Samra to 3 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bou Samra practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Bou Samra's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Bou Samra is licensed in Pennsylvania.

CMS data shows 589 Medicare services from Dr. Bou Samra across 11 procedure codes in 2024, for 300 Medicare patients. Medicare paid $37,606 for them.

CMS counts 300 Medicare patients who saw Dr. Bou Samra in 2024. The largest group is 65 to 74, with 150 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bou Samra's median patient age at 74, with 45% women.

In 2024, Dr. Bou Samra wrote 6,785 Medicare Part D claims for 724 patients. 86% of them were for generic drugs. CMS names the drug for 6,515 of them, across 73 drugs with 11 or more claims each, at $1,013,788 in total drug cost. In 2023, CMS named 5,804 claims across 73 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Bou Samra for performance year 2024, reported as part of a group. Dr. Bou Samra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 55 procedures of coronary angioplasty and stenting by Dr. Bou Samra, more than 86% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 484 general payments to Dr. Bou Samra from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,729.